Heart Failure News and Research RSS Feed - Heart Failure News and Research

Heart failure (HF) is a condition in which a problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs. It should not be confused with cardiac arrest or myocardial infarction.
Particulate matter, NO2 air pollution associated with increased risk of heart attacks

Particulate matter, NO2 air pollution associated with increased risk of heart attacks

Particulate matter and NO2 air pollution are associated with increased risk of severe heart attacks despite being within European recommended levels, according to research presented at ESC Congress today by Dr Jean-Francois Argacha, a cardiologist at University Hospital Brussels (UZ Brussel-Vrije Universiteit Brussel), in Belgium. [More]
Peri-infarct pacing may not be beneficial in patients with large myocardial infarction

Peri-infarct pacing may not be beneficial in patients with large myocardial infarction

In patients with a large myocardical infarction (MI), pacing, with the left ventricular (LV) lead placed in the area of the lesion (peri-infarct) did not prevent further enlargement of the heart (remodeling), nor did it improve functional or clinical outcomes after 18 months, according to results of the Pacing Remodeling Prevention Therapy trial (PRomPT) trial. [More]
ESC Guidelines recommend DNA analysis for post mortem assessment in young sudden death victims

ESC Guidelines recommend DNA analysis for post mortem assessment in young sudden death victims

ESC Guidelines published today recommend DNA analysis as a fundamental component of post mortem assessment in young sudden death victims. Identification of a genetic cause helps to quickly diagnose and protect relatives. [More]

Individually tailored treatment may help reduce mortality risk in patients undergoing routine surgeries

Cholecystectomy and treatment for inguinal, femoral, umbilical, or abdominal hernia are common surgeries and are considered routine in Germany. In an original article in the current edition of Deutsches Ärzteblatt International (Dtsch Arztebl Int 112: 535-43), Ulrike Nimptsch and Thomas Mansky show that fewer than 0.5% of patients die as a result of such surgeries. [More]
Individuals having high blood levels of two closely related proteins experience few adverse health events

Individuals having high blood levels of two closely related proteins experience few adverse health events

Individuals previously diagnosed with heart disease may be less likely to experience heart failure, heart attacks, or stroke, or to die from these events, if they have higher blood levels of two very closely related proteins, according to a new study led by a UC San Francisco research team. [More]
Inpatient palliative care visits associated with improved quality of life for patients with heart failure

Inpatient palliative care visits associated with improved quality of life for patients with heart failure

A recent randomized trial conducted by researchers at Abbott Northwestern Hospital, part of Allina Health, found that inpatient palliative care (PC) visits were associated with improved quality of life and symptom burden for patients with heart failure (HF). [More]
Amgen to present data on Repatha (evolocumab) and observational studies at ESC Congress 2015

Amgen to present data on Repatha (evolocumab) and observational studies at ESC Congress 2015

Amgen today announced that it will present six abstracts at the upcoming ESC Congress 2015, organized by the European Society of Cardiology, being held Aug. 29 – Sept. 2 in London. [More]
Novel ESC paper highlights significance of e-health in tackling heart disease

Novel ESC paper highlights significance of e-health in tackling heart disease

E-health is vital to winning the battle against heart disease, European cardiology leaders said today in a European Society of Cardiology position paper published in European Heart Journal. The novel paper outlines how the ESC will exploit e-health in education and research, while tackling issues of quality control and data security. [More]
Berg and University of Miami extend partnership to battle cardiac dysfunction, heart failure

Berg and University of Miami extend partnership to battle cardiac dysfunction, heart failure

Berg, a Boston-based biopharmaceutical company, and the University of Miami Leonard M. Miller School of Medicine are extending its collaboration to battle cardiac dysfunction and heart failure. According to the American Heart Association, cardiovascular disease is the leading global cause of death, accounting for 17.3 million deaths per year, a number that is expected to grow to more than 23.6 million by 2030. [More]
Cyberonics, Sorin provide update on pending business combination

Cyberonics, Sorin provide update on pending business combination

Cyberonics, Inc. and Sorin S.p.A. today announced an update on various matters relating to their pending business combination (the "Transaction"). [More]
Cyberonics reports record worldwide net sales of $81.0 million for first fiscal quarter 2016

Cyberonics reports record worldwide net sales of $81.0 million for first fiscal quarter 2016

Cyberonics, Inc. today announced results for the quarter ended July 24, 2015. [More]
GARFIELD-AF data to demonstrate impact of antithrombotic treatment patterns on AF patients at ESC Congress 2015

GARFIELD-AF data to demonstrate impact of antithrombotic treatment patterns on AF patients at ESC Congress 2015

New analyses from the Global Anticoagulant Registry in the Field - Atrial Fibrillation (GARFIELD-AF) will be presented at ESC Congress 2015 to be held in London, United Kingdom, from August 29 to September 2, 2015. [More]
Hospira announces TGA approval of Inflectra (infliximab) for treatment of eight inflammatory conditions

Hospira announces TGA approval of Inflectra (infliximab) for treatment of eight inflammatory conditions

Hospira today announced that Inflectra (infliximab), the first monoclonal antibody (mAb) biosimilar therapy, has been registered in Australia. This registration paves the way for the Federal Government to reduce the cost of some of the most expensive medicines on the Pharmaceutical Benefits Scheme (PBS). [More]
Ancient Chinese practice lowers hypertension, may lessen risks of stroke and heart disease

Ancient Chinese practice lowers hypertension, may lessen risks of stroke and heart disease

Patients with hypertension treated with acupuncture experienced drops in their blood pressure that lasted up to a month and a half, researchers with the Susan Samueli Center for Integrative Medicine have found. [More]
Only 1 in 10 heart failure patients referred to cardiac rehabilitation program after hospitalization

Only 1 in 10 heart failure patients referred to cardiac rehabilitation program after hospitalization

Only 1 in 10 heart failure patients is referred to a cardiac rehabilitation program after being hospitalized, despite strong evidence that such exercise programs improve quality of life and reduce the likelihood of future hospitalizations. [More]
Loyola implants new percutaneous aortic heart valve that does not require open surgery

Loyola implants new percutaneous aortic heart valve that does not require open surgery

Loyola University Medical Center is the first center in Illinois to implant a new percutaneous aortic heart valve that does not require open heart surgery. [More]
Psychological disorders in COPD patients predict early hospital readmission

Psychological disorders in COPD patients predict early hospital readmission

Researchers from The University of Texas Medical Branch at Galveston found that people with a psychological condition such as depression, anxiety, psychosis, or alcohol/drug abuse are more likely to be readmitted early into a hospital for complications of chronic obstructive pulmonary disease. [More]
ESC Congress to highlight results from global trials in six press conferences

ESC Congress to highlight results from global trials in six press conferences

Members of the press will be the first to hear the highly anticipated results from global trials in six press conferences devoted to hot lines research. [More]
Common marker can help identify patients at high risk for deadly cardiac events

Common marker can help identify patients at high risk for deadly cardiac events

A marker commonly used to determine if a patient is having a heart attack can also be used to identify stable patients at high risk for deadly cardiac events, according to a new study led by investigators at Brigham and Women's Hospital. [More]
Researchers elucidate mechanism that induces skeletal muscle atrophy in patients with congestive heart failure

Researchers elucidate mechanism that induces skeletal muscle atrophy in patients with congestive heart failure

It is a paradox: Patients with advanced congestive heart failure lose skeletal muscle mass, but their heart muscles become enlarged to provide the body with an adequate supply of blood and thus with oxygen. It has long been known that the protein angiotensin II plays a villainous role in this process, but the exact mechanism has remained unclear. [More]
Advertisement